NSC expo
Subscribe or Register
View Cart  

Earn recertification points from the Board of Certified Safety Professionals by taking a quiz about this issue.

What's Your Opinion?

Should employers' injury and illness data be made public?

Take the poll and add your comment.

Vote   Results


 

Does your CEO 'Get it?'

Tell us why on the submission form and your CEO could appear among the 2017 selections.

Get the news that's
important to you.

Sign up for Safety+Health’s free monthly newsletters on:

  • Construction
  • Health Care Workers
  • Manufacturing
  • Mining, Oil and Gas
  • Office Safety Tips
  • Transportation
  • Worker Health and Wellness
  • Subscribe today

    Certain painkillers may boost heart attack risk: study

    June 3, 2013

    Tags
    • / Print
    • Reprints
    • Text Size:
      A A

    Oxford, England – Taking high doses of ibuprofen or similar painkillers may increase the risk of heart attack, according to a study from the University of Oxford.

    Researchers analyzed 639 randomized trials of non-steroidal anti-inflammatory drugs and found that a daily dose of 2,400 milligrams of ibuprofen or 150 milligrams of diclofenac increased the risk of heart attack, stroke or death by one-third, the study abstract states.

    Taking NSAIDs also was associated with double the risk of heart failure and a higher chance of gastrointestinal complications such as ulcers.

    Researchers noted that the risk was higher among people with underlying risk factors, such as elevated blood pressure or cholesterol, and suggested doctors account for these risk factors before prescribing NSAIDs.

    The study was published online May 30 in the journal The Lancet.

    Post a comment to this article

    Safety+Health welcomes comments that promote respectful dialogue. Please stay on topic. Comments that contain personal attacks, profanity or abusive language – or those aggressively promoting products or services – will be removed. We reserve the right to determine which comments violate our comment policy.